Troglitazone
Generic Name: troglitazone
Manufactured by SANKYO. Dosage form: TABLET. Route: ORAL. Active ingredients: TROGLITAZONE (400MG). Application: NDA020719.
Overview
Manufactured by SANKYO. Dosage form: TABLET. Route: ORAL. Active ingredients: TROGLITAZONE (400MG). Application: NDA020719.
Dosage
Available as tablet for oral use.
Related Medications
Naxitamab
naxitamab
Glycolipid Disialoganglioside-directed Antibody [EPC]
11 DESCRIPTION Naxitamab-gqgk is a glycolipid disialoganglioside (GD2)-binding recombinant humanized monoclonal IgG1 antibody, that contains human framework regions and murine complementarity-determining regions. Naxitamab-gqgk is produced in a Chinese hamster ovary cell line and has an approximate molecular weight of 144 kDa without glycosylation.
Harpagophytum Procumbens, Arnica Montana, Boswellia Serrata, Salix Alba
harpagophytum procumbens, arnica montana, boswellia serrata, salix alba
Purpose Purpose* Trauma, muscle pain and stiffness
Macitentan Non-micronized
macitentan non-micronized
Dosage form: POWDER. Active ingredients: MACITENTAN (1 kg/kg). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.